304 related articles for article (PubMed ID: 15216890)
1. Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators.
Wilson L; Panda D; Jordan MA
Cell Struct Funct; 1999 Oct; 24(5):329-35. PubMed ID: 15216890
[TBL] [Abstract][Full Text] [Related]
2. Substoichiometric binding of taxol suppresses microtubule dynamics.
Derry WB; Wilson L; Jordan MA
Biochemistry; 1995 Feb; 34(7):2203-11. PubMed ID: 7857932
[TBL] [Abstract][Full Text] [Related]
3. Microtubule treadmilling: what goes around comes around.
Margolis RL; Wilson L
Bioessays; 1998 Oct; 20(10):830-6. PubMed ID: 9819570
[TBL] [Abstract][Full Text] [Related]
4. Physiochemical aspects of tubulin-interacting antimitotic drugs.
Correia JJ; Lobert S
Curr Pharm Des; 2001 Sep; 7(13):1213-28. PubMed ID: 11472263
[TBL] [Abstract][Full Text] [Related]
5. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.
Derry WB; Wilson L; Jordan MA
Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803
[TBL] [Abstract][Full Text] [Related]
6. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: a possible mechanistic basis for its antitumor action.
Panda D; Miller HP; Islam K; Wilson L
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10560-4. PubMed ID: 9380674
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics.
Downing KH
Annu Rev Cell Dev Biol; 2000; 16():89-111. PubMed ID: 11031231
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action cryptophycin. Interaction with the Vinca alkaloid domain of tubulin.
Smith CD; Zhang X
J Biol Chem; 1996 Mar; 271(11):6192-8. PubMed ID: 8626409
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of tubulin exchange at microtubule ends at low vinblastine concentrations.
Jordan MA; Wilson L
Biochemistry; 1990 Mar; 29(11):2730-9. PubMed ID: 2346745
[TBL] [Abstract][Full Text] [Related]
11. Use of drugs to study role of microtubule assembly dynamics in living cells.
Jordan MA; Wilson L
Methods Enzymol; 1998; 298():252-76. PubMed ID: 9751887
[No Abstract] [Full Text] [Related]
12. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
13. Determination of the net exchange rate of tubulin dimer in steady-state microtubules by fluorescence correlation spectroscopy.
Neumann T; Kirschstein SO; Camacho Gomez JA; Kittler L; Unger E
Biol Chem; 2001 Mar; 382(3):387-91. PubMed ID: 11347885
[TBL] [Abstract][Full Text] [Related]
14. Temperature sensitivity of vinblastine-induced tubulin polymerization in the presence of microtubule-associated proteins.
Prasad V; Jordan MA; Ludueña RF
J Protein Chem; 1992 Oct; 11(5):509-15. PubMed ID: 1449600
[TBL] [Abstract][Full Text] [Related]
15. Indirubin, a bis-indole alkaloid binds to tubulin and exhibits antimitotic activity against HeLa cells in synergism with vinblastine.
Mohan L; Raghav D; Ashraf SM; Sebastian J; Rathinasamy K
Biomed Pharmacother; 2018 Sep; 105():506-517. PubMed ID: 29883946
[TBL] [Abstract][Full Text] [Related]
16. Molecular cytology of microtubules.
Maccioni RB
Revis Biol Celular; 1986; 8():1-124. PubMed ID: 2892233
[No Abstract] [Full Text] [Related]
17. Unique functional characteristics of the polymerization and MAP binding regulatory domains of plant tubulin.
Hugdahl JD; Bokros CL; Hanesworth VR; Aalund GR; Morejohn LC
Plant Cell; 1993 Sep; 5(9):1063-80. PubMed ID: 8104575
[TBL] [Abstract][Full Text] [Related]
18. Microtubules and Cell Division: Potential Pharmacological Targets in Cancer Therapy.
Sebastian J; Rathinasamy K
Curr Drug Targets; 2023; 24(11):889-918. PubMed ID: 37519203
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of antitumor drugs that interact with microtubules and tubulin.
Jordan MA
Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):1-17. PubMed ID: 12678749
[TBL] [Abstract][Full Text] [Related]
20. Rhazinilam mimics the cellular effects of taxol by different mechanisms of action.
David B; Sévenet T; Morgat M; Guénard G; Moisand A; Tollon Y; Thoison O; Wright M
Cell Motil Cytoskeleton; 1994; 28(4):317-26. PubMed ID: 7954858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
